|
Volumn 7, Issue 6, 2005, Pages R940-R952
|
Targeted therapy against Bcl-2-related proteins in breast cancer cells
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
PROTEIN BCL 2;
PROTEIN BCL X;
TETRAZOLIUM;
THIAZOLE DERIVATIVE;
THIAZOLYL BLUE;
ANIMAL;
APOPTOSIS;
BIOSYNTHESIS;
BREAST TUMOR;
DIAGNOSTIC USE;
DRUG EFFECTS;
DRUG RESISTANCE;
FEMALE;
GENETICS;
HUMAN;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PROTO ONCOGENE;
TUMOR CELL CULTURE;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BCL-X PROTEIN;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENES, BCL-2;
HUMANS;
MICE;
MICE, NUDE;
OLIGONUCLEOTIDES, ANTISENSE;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TETRAZOLIUM SALTS;
THIAZOLES;
TRANSPLANTATION, HETEROLOGOUS;
TUMOR CELLS, CULTURED;
|
EID: 34447630051
PISSN: None
EISSN: 1465542X
Source Type: Journal
DOI: 10.1186/bcr1323 Document Type: Article |
Times cited : (115)
|
References (0)
|